FMR LLC 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-08 09:07 am Purchase | 2025-06-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | FMR LLC | 1,414,190 10.200% | 1,396,091 (+7713.64%) | Filing |